Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients
Tredese, F.; Maggino, T.; Salvagno, L.; Marchesoni, D.; Chizzolini, M.; Pattaro, R.F.
European Journal of Gynaecological Oncology 6(2): 136-138
1985
ISSN/ISBN: 0392-2936 PMID: 4029198 Document Number: 262257
A comparison between plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients has been performed. The LBSA level appears more specific then the CEA, especially for ovarian cancer. This finding has promoted a longitudinal study to show if LBSA test may prove a reliable marker of disease in ovarian cancer patients.